Traws Pharma (TRAW) Earnings Date, Estimates & Call Transcripts $1.98 -0.01 (-0.50%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$1.99 +0.01 (+0.51%) As of 04/17/2025 04:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Traws Pharma Earnings Summary Latest Q4 2024 & Study Update Earnings DateMar. 31EstimatedConsensus EPS (Mar. 31) -$7.00 Actual EPS (Mar. 31) $95.66 Beat By $102.66 Actual Revenue (Mar. 31) $0.06MTraws Pharma released Q4 2024 & Study Update earnings on March 31, 2025, reporting an EPS of $95.66, which beat the consensus estimate of -$7.00 by $102.66. Quarterly revenue was reported to be $0.06 million, below analysts' expectations of $0.06 million. Traws Pharma currently has a trailing EPS of -$40.90Q4 2024 & Study Update Earnings ResourcesQ4 2024 & Study Update Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K)Powered by Get Traws Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Traws Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTRAW Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TRAW Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Traws Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.31-$0.31-$0.31Q2 20251-$0.33-$0.33-$0.33Q3 20251-$0.35-$0.35-$0.35Q4 20251-$0.36-$0.36-$0.36FY 20254($1.35)($1.35)($1.35) Traws Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails3/31/2025Q4 2024 & Study Update-$7.00$95.66+$102.66$95.66$0.06M$0.06M8/15/2024Q2 2024--$4.87 -$4.87-$4.87-$0.06M5/15/2024Q1 2024-$0.24-$0.24--$0.24$0.06M$0.06M4/1/2024Q4 2023--$0.20 -$0.20-$0.20-$0.06M11/14/2023Q3 2023-$0.26-$0.23+$0.03-$0.23$0.06M$0.06M8/10/2023Q2 2023-$0.29-$0.20+$0.09-$0.20$0.06M$0.06M5/15/2023Q1 2023-$0.27-$0.28 -$0.01-$0.28$0.06M$0.06M Traws Pharma Earnings - Frequently Asked Questions When did Traws Pharma announce their last quarterly earnings? Traws Pharma (NASDAQ:TRAW) last announced its quarterly earning data on Monday, March 31, 2025. Learn more on TRAW's earnings history. Did Traws Pharma beat their earnings estimates last quarter? In the previous quarter, Traws Pharma (NASDAQ:TRAW) reported $95.66 earnings per share (EPS) to beat the analysts' consensus estimate of ($7.00) by $102.66. Learn more on analysts' earnings estimate vs. TRAW's actual earnings. How can I listen to Traws Pharma's earnings conference call? The conference call for Traws Pharma's latest earnings report can be listened to online. Listen to Conference Call How can I read Traws Pharma's conference call transcript? The conference call transcript for Traws Pharma's latest earnings report can be read online. Read Transcript How much revenue does Traws Pharma generate each year? Traws Pharma (NASDAQ:TRAW) has a recorded annual revenue of $226,000.00. How much profit does Traws Pharma generate each year? Traws Pharma (NASDAQ:TRAW) has a recorded net income of -$18.95 million. TRAW has generated -$40.90 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies BLUE Earnings Date IPSC Earnings Date OTLK Earnings Date TNYA Earnings Date AADI Earnings Date ANEB Earnings Date SKYE Earnings Date STTK Earnings Date LTRN Earnings Date PRLD Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Aviation Unveils NYC Network Ahead of Key Earnings Report3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions Ahead This page (NASDAQ:TRAW) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Traws Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Traws Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
